These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10719063)

  • 1. Binding properties of [3H]gacyclidine (cis(pip/me)-1-[1-(2-thienyl)-2-methylcyclohexyl]piperidine) enantiomers in the rat central nervous system.
    Hirbec H; Teilhac J; Kamenka J; Privat A; Vignon J
    Brain Res; 2000 Mar; 859(2):177-92. PubMed ID: 10719063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding properties of [3H]gacyclidine in the rat central nervous system.
    Hirbec H; Privat A; Vignon J
    Eur J Pharmacol; 2000 Feb; 388(3):235-9. PubMed ID: 10675731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures.
    Hirbec H; Kamenka JM; Privat A; Vignon J
    J Neurochem; 2001 Apr; 77(1):190-201. PubMed ID: 11279275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.
    Hirbec H; Gaviria M; Vignon J
    CNS Drug Rev; 2001; 7(2):172-98. PubMed ID: 11474423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of gacyclidine enantiomers with 'non-NMDA' binding sites in the rat central nervous system.
    Hirbec H; Kamenka JM; Privat A; Vignon J
    Brain Res; 2001 Mar; 894(2):189-92. PubMed ID: 11251192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of gacyclidine enantiomers after experimental spinal cord injury in rats: possible involvement of an active transport system.
    Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Lallemand A; Millart H; D'Arbigny P; Vistelle R
    J Pharm Sci; 2001 Jan; 90(1):70-8. PubMed ID: 11064380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of gacyclidine enantiomers in plasma and spinal cord after single enantiomer administration in rats.
    Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Millart H; D'Arbigny P; Vistelle R
    Int J Pharm; 2001 Oct; 229(1-2):147-53. PubMed ID: 11604267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of gacyclidine enantiomers in spinal cord extracellular fluid.
    Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Lallemand A; D'Arbigny P; Millart H; Vistelle R
    Pharm Res; 2000 Feb; 17(2):148-53. PubMed ID: 10751028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury.
    Feldblum S; Arnaud S; Simon M; Rabin O; D'Arbigny P
    J Neurotrauma; 2000 Nov; 17(11):1079-93. PubMed ID: 11101210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiography.
    Aanonsen LM; Seybold VS
    Synapse; 1989; 4(1):1-10. PubMed ID: 2549651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.
    Gundlach AL; Largent BL; Snyder SH
    J Neurosci; 1986 Jun; 6(6):1757-70. PubMed ID: 3012017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity.
    Berman FW; Murray TF
    J Biochem Toxicol; 1996; 11(5):217-26. PubMed ID: 9110243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: dose-window and time-window effects.
    Gaviria M; Privat A; d'Arbigny P; Kamenka JM; Haton H; Ohanna F
    J Neurotrauma; 2000 Jan; 17(1):19-30. PubMed ID: 10674755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM; Lapchak PA; Quirion R
    Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine and the phencyclidine derivative BTCP differently inhibit [3H]TCP binding to high- and low-affinity sites.
    Maurice T; Vignon J
    Eur J Pharmacol; 1991 Jan; 192(1):169-72. PubMed ID: 1674915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gacyclidine (Beaufour-Ipsen).
    Mitha AP; Maynard KI
    Curr Opin Investig Drugs; 2001 Jun; 2(6):814-9. PubMed ID: 11572662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.